MCYSX
Price
$16.06
Change
+$0.45 (+2.88%)
Updated
Jul 31 closing price
Net Assets
124.81M
RNWBX
Price
$100.57
Change
+$1.95 (+1.98%)
Updated
Jul 31 closing price
Net Assets
90.71B
Interact to see
Advertisement

MCYSX vs RNWBX

MCYSX vs RNWBX Comparison Chart in %
View a ticker or compare two or three
VS
MCYSX vs. RNWBX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCYSX is a Buy and RNWBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWBX has more cash in the bank: 90.7B vs. MCYSX (125M). MCYSX pays higher dividends than RNWBX: MCYSX (1.07) vs RNWBX (0.42). MCYSX was incepted earlier than RNWBX: MCYSX (9 years) vs RNWBX (24 years). RNWBX (1.66) is less costly to investors than MCYSX (1.38). MCYSX is a more actively managed with annual turnover of: 189.00 vs. RNWBX (46.00). MCYSX has a lower initial minimum investment than RNWBX: MCYSX (0) vs RNWBX (250). MCYSX annual gain was more profitable for investors over the last year : 38.00 vs. RNWBX (20.43). MCYSX return over 5 years is better than : 29.02 vs. RNWBX (12.95).
MCYSXRNWBXMCYSX / RNWBX
Total Expense Ratio1.011.6661%
Annual Report Gross Expense Ratio1.381.6683%
Fund Existence9 years24 years-
Gain YTD21.75913.344163%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets125M90.7B0%
Annual Yield % from dividends1.070.42254%
Returns for 1 year38.0020.43186%
Returns for 3 years73.3539.93184%
Returns for 5 years29.0212.95224%
Returns for 10 yearsN/A98.57-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GTDCX45.480.98
+2.20%
Invesco Emerging Markets ex-China C
FSSGX16.130.24
+1.51%
Fidelity SAI Sustainable Em Markets Eq
FSGEX20.810.01
+0.05%
Fidelity Series Global ex US Index
PRLAX24.71-0.01
-0.04%
T. Rowe Price Latin America
JPVZX22.58-0.13
-0.57%
JPMorgan Developed International ValueR2